AstraZeneca Plc is discussing a partnership deal with Summit Therapeutics Inc. in which it could pay as much as $15 billion ...

Initial Collaboration Launches at Yukon, OK Site AUSTIN, TX / ACCESS Newswire / July 1, 2025 / Tekton Research is proud to ...

Summit Partners Growth Equity Fund XII (“Summit XII”) launched fundraising in late April 2024 and held its closing after approximately five months with $9.5 billion in capital.

Press Release Summit Partners, a global alternative investment firm, today announced the final closing of its second Europe growth equity fund. The fundraising was launched earlier this year, and ...

Growth-equity pioneer Summit Partners has raised new funds to focus on European and venture-capital deals, taking advantage of surging demand for vehicles that invest in fast-growing young companies.

Summit Partners' newest fund comes about three years after the global private equity firm, with its headquarters in the Back Bay, closed its predecessor at $8.35 billion.

Summit Partners Growth Equity Fund IX-A, L.P. now holds 25,677,643 shares, Summit Partners Growth Equity Fund IX-B, L.P. has 16,032,765 shares, Summit Investors GE IX/VC IV, LLC owns 179,239 ...

Additionally, Michael Medici, a managing director of Summit Partners, sits on the board of Klaviyo. At $36.75 a share, those shares are worth roughly $2 billion.

U.S. private equity firm Summit Partners is looking to sell a stake in Swiss wealth manager Cinerius Financial Partners amid increasing consolidation in the sector, two people familiar with the ...

Summit Partners, a leading global growth equity firm, has recently completed a sale of shares in Klaviyo , Inc. (NYSE: KVYO), a prominent software services provider.The transaction involved the ...